(October 31 19:36) Tech.einnews.com
… by preventing its degradation.
Similarly, nanotechnology can also enhance immunogenicity and … . Emergex, is owned by Singaporean venture capital firm Vickers Venture … current vaccine development challenges. Technology advances have enabled the development …
You can find the original article
here